Researchers have used Nrf2 activators, including dimethyl fumarate, tert-butyl hydroquinone, or carnosic acid, which are used as adjuvants and vitamin D to reduce its dose in the U937 AML cell line to prevent the toxicity of calcium [194, 195]. This evidence concerns the gene NFE2L2 and acute myeloid leukemia.